Experienced in Thrombocytopenia

Jose M. Moraleda

Murcia, MU, ES 
Experienced in Thrombocytopenia
Murcia, MU, ES 
OverviewLocationsClinical Research

Overview

Jose Moraleda practices in Murcia, Spain. Moraleda is rated as an Experienced expert by MediFind in the treatment of Thrombocytopenia. Their top areas of expertise are Multiple Myeloma, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Non-Hodgkin Lymphoma, and Bone Marrow Transplant.

Their clinical research consists of co-authoring 135 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Thrombocytopenia.

Locations

Murcia, MU 30120, Spain
Other Locations
El Palmar, MU 30120, Spain
Madrid, MD, Spain
Barcelona, CT, Spain
Spain
Valencia, VC, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Phase 2 Study of the Infusion of Differentiated Autologous T-cells From Peripheral Blood, Expanded and Transduced With a Lentivirus to Express a Chimeric Antigen Receptor With Anti-CD19 Specificity (A3B1) Conjugated With the Co-stimulatory Regions 4-1BB and CD3z (ARI-0001 Cells) in Patients With CD19+ Acute Lymphoid Leukemia Resistant or Refractory to Therapy
Phase 2 Study of the Infusion of Differentiated Autologous T-cells From Peripheral Blood, Expanded and Transduced With a Lentivirus to Express a Chimeric Antigen Receptor With Anti-CD19 Specificity (A3B1) Conjugated With the Co-stimulatory Regions 4-1BB and CD3z (ARI-0001 Cells) in Patients With CD19+ Acute Lymphoid Leukemia Resistant or Refractory to Therapy
Enrollment Status: Active_not_recruiting
Publish Date: June 26, 2024
Intervention Type: Drug
Study Drug: ARI-0001 cells
Study Phase: Phase 2
Pilot Study of the Infusion of Differentiated Autologous T-cells From Peripheral Blood, Expanded and Transduced With a Lentivirus to Express a Chimeric Antigen Receptor With Anti-BCMA (TNFRSF17) Specificity Humanized Conjugated With the Co-stimulatory Region 4-1BB and Signal-transduction CD3z (ARI0002h) in Patients With Relapsed/Refractory Multiple Myeloma With Previous Treatment With Proteasome Inhibitor, Immunomodulatory Drug and Anti-CD38 Monoclonal Antibody
Pilot Study of the Infusion of Differentiated Autologous T-cells From Peripheral Blood, Expanded and Transduced With a Lentivirus to Express a Chimeric Antigen Receptor With Anti-BCMA (TNFRSF17) Specificity Humanized Conjugated With the Co-stimulatory Region 4-1BB and Signal-transduction CD3z (ARI0002h) in Patients With Relapsed/Refractory Multiple Myeloma With Previous Treatment With Proteasome Inhibitor, Immunomodulatory Drug and Anti-CD38 Monoclonal Antibody
Enrollment Status: Unknown
Publish Date: August 28, 2023
Intervention Type: Biological
Study Drug: Adult Differentiated Autologous T-cells with Anti-BCMA Specificity
Study Phase: Phase 1/Phase 2
View 1 Less Clinical Trial

135 Total Publications

Defibrotide for Protecting Against and Managing Endothelial Injury in Hematologic Malignancies and COVID-19.
Defibrotide for Protecting Against and Managing Endothelial Injury in Hematologic Malignancies and COVID-19.
Journal: Biomolecules
Published: May 02, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Moraleda's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 33 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile